CM
COCH icon

Crestline Management’s Envoy Medical COCH Stock Holding History

Crestline Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$1.02M – 152
2023
Q2 		$1.02M Hold
100,000
– – 0.11% 138
2023
Q1 		$1M Buy
+100,000
New +$1M 0.12% 134
2022
Q4 		– Sell
-44,000
Closed -$433K – 175
2022
Q3 		$433K Buy
+44,000
New +$432K 0.06% 158

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Crestline Management's COCH Position: Q3 2023 in Review

Crestline Management sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Crestline Management first reported a position in COCH in Q3 2022 and held it in 3 quarters. The position peaked at $1.02M in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

  • Crestline Management reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
  • Crestline Management sold 100,000 Envoy Medical shares in Q3 2023, an estimated $1.02M.
  • Crestline Management first reported a position in Envoy Medical in Q3 2022 and held it in 3 quarters.
  • Crestline Management's Envoy Medical position peaked at $1.02M in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on Crestline Management's 13F filing for Q3 2023, filed 14 Nov 2023.